INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← Nutrition & Adequacy / Health Desk

B12 supplementation: what the small dose-comparison trial tested

A marginal-deficiency study is not a treatment protocol for severe deficiency.

Whole-food ingredients prepared without added oil

Illustrative food image, not a photograph of the study intervention.

Identify the target population

This randomized trial, published online in 2018 and in the 2019 journal volume, enrolled 40 vegans and vegetarians with marginal vitamin B12 deficiency. It compared two sublingual supplementation schedules over 12 weeks using a double-blind, parallel design. The population matters: marginal biochemical deficiency is not the same clinical situation as severe deficiency with neurological symptoms. The study can inform interpretation of the tested regimens in its own setting, but it cannot establish a universal treatment plan for every cause, severity, or presentation of low B12. Its main contribution is an intervention comparison, not a food-source survey.

Del Bo' C, Riso P, Gardana C, Brusamolino A et al.. Clinical nutrition (Edinburgh, Scotland), 2019. PMID 29499976 · DOI

Two active schedules, not supplementation versus nothing

The lower-dose schedule supplied 50 micrograms daily, totaling 350 micrograms per week. The higher-dose schedule supplied 2,000 micrograms as a single weekly dose. Both were sublingual, so the trial does not compare that route with swallowed tablets or injections. The contrast also changes frequency as well as total weekly amount. It should therefore not be reduced to a simple experiment in which only dose size varied while everything else stayed identical. Both groups received active supplementation rather than one group receiving no B12.

Del Bo' C, Riso P, Gardana C, Brusamolino A et al.. Clinical nutrition (Edinburgh, Scotland), 2019. PMID 29499976 · DOI

What improved during follow-up

Serum B12 increased during supplementation in both groups. Related metabolic markers also changed: methylmalonic acid and homocysteine decreased over time, while holotranscobalamin increased. The abstract reports a time-by-treatment interaction for serum B12 as well as no between-group difference for the subsequent marker comparison. That wording is a reason not to claim that every response was identical. The authors concluded that both regimens restored adequate serum concentrations under their experimental conditions. Lack of a detected difference should not be rewritten as formal proof of equivalence.

Del Bo' C, Riso P, Gardana C, Brusamolino A et al.. Clinical nutrition (Edinburgh, Scotland), 2019. PMID 29499976 · DOI

Keep the safety boundary specific

These results concern biochemical improvement in a small, selected group over roughly three months. They do not establish prevention of neurological injury, long-term adherence, or the best regimen for malabsorption or severe symptomatic deficiency. This article reports the study schedules for interpretation rather than prescribing either one to an individual reader. It also does not claim that unfortified plant foods can replace the supplements tested. Questions about a low result or symptoms require clinical assessment; a short active-dose trial cannot settle diagnosis, urgency, or the appropriate route of treatment.

Del Bo' C, Riso P, Gardana C, Brusamolino A et al.. Clinical nutrition (Edinburgh, Scotland), 2019. PMID 29499976 · DOI